共 50 条
- [11] Pharmacodynamic Effects on Biochemical Markers of Bone Turnover and Pharmacokinetics of the Cathepsin K Inhibitor, ONO-5334, in an Ascending Multiple-Dose, Phase 1 Study JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 52 (03): : 306 - 318
- [12] Bone turnover markers and pharmacokinetics of a new sustained-release formulation of the cathepsin K inhibitor, ONO-5334, in healthy post-menopausal women Journal of Bone and Mineral Metabolism, 2015, 33 : 93 - 100
- [14] Effects of novel cathepsin K inhibitor ONO-5334 on bone resorption markers: a study of four sustained release formulations with different pharmacokinetic patterns Journal of Bone and Mineral Metabolism, 2014, 32 : 447 - 454
- [16] ONO-5334, a cathepsin K inhibitor, improves bone strength by preferentially increasing cortical bone mass in ovariectomized rats Journal of Bone and Mineral Metabolism, 2014, 32 : 645 - 652
- [19] Cortical bone mineral density is increased by the cathepsin K inhibitor ONO-5334, which leads to a robust increase in bone strength: results from a 16-month study in ovariectomised cynomolgus monkeys Journal of Bone and Mineral Metabolism, 2019, 37 : 636 - 647